Loading insider details...
Beta
Latest Form 4 (Jul 11, 2026): Grant/Award of 24,400 RIGL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 11, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 24,400 | n/a |
| May 20, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 5,750 | n/a |
| Jun 3, 2025 | NEOGENOMICS INC (NEO) | Grant/Award | 12,254 | n/a |
| May 28, 2025 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 2,500 | n/a |
| Aug 13, 2024 | NEOGENOMICS INC (NEO) | Exercise/Conversion | 11,336 | n/a |
| Jun 4, 2024 | NEOGENOMICS INC (NEO) | Grant/Award | 8,672 | n/a |
| May 29, 2024 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 25,000 | n/a |
| Aug 14, 2023 | NEOGENOMICS INC (NEO) | Grant/Award | 8,353 | n/a |
| Jul 12, 2023 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 25,000 | n/a |
| Jul 21, 2022 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 15,000 | n/a |